A key cost-saving provision of the Inflation Reduction Act (IRA) goes into effect in the new year, limiting annual out-of-pocket spending on prescription drugs to $2,000 for Medicare beneficiaries.
Medicare will begin capping prescription drug costs at $2,000 annually from January 1—a move that's widely expected to benefit millions of Americans.
Billionaire entrepreneur Mark Cuban has been vocal about reshaping the U.S. health care system for years. During recent appearances on podcasts Fishbowl with Jules Terpak and Ground Truths with Dr.
Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, ...
As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...
A new $2,000 cap on out-of-pocket spending on medications for Medicare Part D beneficiaries goes ... "Research from AARP ...